Wealthcreatures.com
KPIT TECH 14% blast π£π£ 499.90 143 TO 499.90 π―π
KPIT TECH
FRESH ATH
524 π―
Getting Ready For 4x
143 TO 524 π―π Done β Till Now
Next Test Levels # 572/648/770++
FRESH ATH
524 π―
Getting Ready For 4x
143 TO 524 π―π Done β Till Now
Next Test Levels # 572/648/770++
Wealthcreatures.com
NIDAN DIAGNOSTICS IPO PRICE # 125 LISTED IN SME # 1000 LOT SIZE CURRENTLY @ 60.30 (52wk Low) Market Cap - 85cr Book Value - 12.47 High Chances can go to sub 50 levels or even 40 but only on close below 56.90 Value investors shld Keep on Radarβ¦
S/L Hit π
Investors can look at sub 40 zone
Would Review again there in coming Days
Investors can look at sub 40 zone
Would Review again there in coming Days
Wealthcreatures.com
55 TO 324 π― ( ALMOST 6X Done) Cmp - 286.75 Support @ 250/235 Revised Test Levels - 8x/10x/12Γ/15Γ in Medium To longterm KABRA EXTRUSION - Major Game Changer πBATTRIXX ---- Battrixx is the future technologies division of Kabra Extrusion, dedicatedβ¦
KABRA EXTRUSION
12% π£
326 π
12% π£
326 π
Wealthcreatures.com
JEEVAN SCIENTIFIC 10% π£π FRESH 52WK HIGH 135.75 π―π 80 To 135 Done β Till Now
JEEVAN SCIENTIFIC
5% LC To 5% UC
5% LC To 5% UC
Wealthcreatures.com
KOPRAN 226.85 ALL DIPS are Buying opportunity for those who can wait for 2 - 4 - 6 Qtrs Support@ 220/208
KOPRAN
FRESH ATH
π IN 5% UC
276.50π―
FRESH ATH
π IN 5% UC
276.50π―
Wealthcreatures.com
Kopran 36 To 263 Done Till β Now Our Test Levels # 10x/15x β
KOPRAN
36 TO 276 πDONE β TILL NOW
7.5x Done β Till Now
OUR TEST LEVELS # 10X/15X/20Γ
36 TO 276 πDONE β TILL NOW
7.5x Done β Till Now
OUR TEST LEVELS # 10X/15X/20Γ
Wealthcreatures.com
π₯ Diwali Picks π₯ CDSL BSE -Choose Peaceful Investing -Spend Time with Family and Friends
BSE LTD
FRESH ATH
4.5% ππ
1733 π―
FRESH ATH
4.5% ππ
1733 π―
Wealthcreatures.com
LINCOLN PHARMA TODAY RESTESTING SUPPORT LEVELS LOW - 316.70 Good TO ADD FOR DELIVERY IF HAVE PATIENCE
LINCOLN PHARMA
14% blast π£
370
14% blast π£
370
Wealthcreatures.com
TCI EXPRESS From last few days Taking Support @ 1400 zone Resistance @ 1580 The Day it closes above 1600 it would be π
TCI EXPRESS
Fresh ATH
2376
Next levels To watch # 2525/2870/3100+++
Fresh ATH
2376
Next levels To watch # 2525/2870/3100+++
Wealthcreatures.com
BAJAJ HOLDING Ready For 3X πππ Crossed Last High of 3950 Reco@ 1460 & Clearly Told its Wealthcreator Fresh Breakout New 52wk High # 4200 Add on All dips Best To add @ 4050/3900 zone on Dips Next Test Levels # 4444/5050/5555/6161+++
BAJAJ HOLDING
FResh ATH
5339
Now Getting Ready for 5555/6161/6700/7500++
FResh ATH
5339
Now Getting Ready for 5555/6161/6700/7500++
Wealthcreatures.com
MASTEK Rs.250 β¬οΈ NOW 10% Blast π£ 2770
MASTEK
ANOTHER 9% BLAST π£
2922
Once closed above 2960 - 3010 zone should see Fresh breakout & Should Retest ATH in 1 to 2 Qtrs
Our Longterm Test Levels # 5000/6000/6666/7500/10000
ANOTHER 9% BLAST π£
2922
Once closed above 2960 - 3010 zone should see Fresh breakout & Should Retest ATH in 1 to 2 Qtrs
Our Longterm Test Levels # 5000/6000/6666/7500/10000
BSE
π₯π₯
1919 ++
16% Up..
π₯π£π₯π£π₯π£π₯π£
Abhi tak Diwali Chal rahi hai ππ
π₯π₯
1919 ++
16% Up..
π₯π£π₯π£π₯π£π₯π£
Abhi tak Diwali Chal rahi hai ππ
Wealthcreatures.com
Deepak Nitrite Low - 2050 Phenol & Acetone prices have started softening Price damage Seems already Done or very close By Would Take Time to cross 2222/2300 All Dips are buying opportunity Street is expecting Muted Q3 but company can suprise us inβ¦
DEEPAK NITRITE
KEEP π
Closed above 2222 good sign
Next resistance - 2300/2341 and above that momentum wld be back in Action
KEEP π
Closed above 2222 good sign
Next resistance - 2300/2341 and above that momentum wld be back in Action
Deepak Nitrite's prospect continues to be driven by phenolics biz
Deepak Nitrite is seeing strong investor confidence with its stock prices more than doubling year to date. The company, which is an established manufacturer of phenol, acetone, and isopropyl alcohol through its subsidiary Deepak Phenolics, has continued to benefit from rising prices of phenol derivatives.
Global supply disruption for these chemicals during the year benefitted the company. Having created Indiaβs largest phenol-acetone plant, the company will continue to accrue benefits from the countryβs growing demand and import substitutions. Being a basic manufacturer, it also has a good edge over cost competition.
While investment rationale remains strong, in the near term there will be challenges too. Prices of phenol seem to be peaking around current levels, while acetone prices have normalized from their peak over the last two months, said analysts at Motilal Oswal Financial Services post Q2 results. EBIT margin in fine and specialty chemicals dipped for the fourth consecutive quarter and the same for basic chemicals normalized, said analysts.
In the ongoing third quarter, prices continue to correct further. Recent chemical and petrochemical prices data by Emkay Global Financial Services indicates that prices of phenol and acetone in November are down 4.9% and 11.4% over October.
Thus, there may not be benefits from rising realisations. Also, the company had achieved its highest-ever plant utilization rate of 120% in 2QFY22, leaving limited growth in this segment for volume accretion, say analysts.
The longer-term prospects nevertheless remain strong and intact. Having fully integrated manufacturing facilities will help it manage and produce chemicals with a competitive advantage. Deepak Phenolics caters to several end-user industries such as agrochemicals, rubber, pharmaceuticals, paper, textile, detergent, colorants, paints, etc. resulting in a natural hedge, say analysts.
Analysts at JM Financial expect βSales, Ebitda and Earnings per share to post 18%, 18%, and 20% CAGR (compound annual growth rate), respectively, over FY21-24E". Despite an aggressive capex of βΉ1,500 crore over FY23-24, they expect its return on capital employed (pre-tax) to remain 32% over FY23E-24E.
Deepak Nitrite is seeing strong investor confidence with its stock prices more than doubling year to date. The company, which is an established manufacturer of phenol, acetone, and isopropyl alcohol through its subsidiary Deepak Phenolics, has continued to benefit from rising prices of phenol derivatives.
Global supply disruption for these chemicals during the year benefitted the company. Having created Indiaβs largest phenol-acetone plant, the company will continue to accrue benefits from the countryβs growing demand and import substitutions. Being a basic manufacturer, it also has a good edge over cost competition.
While investment rationale remains strong, in the near term there will be challenges too. Prices of phenol seem to be peaking around current levels, while acetone prices have normalized from their peak over the last two months, said analysts at Motilal Oswal Financial Services post Q2 results. EBIT margin in fine and specialty chemicals dipped for the fourth consecutive quarter and the same for basic chemicals normalized, said analysts.
In the ongoing third quarter, prices continue to correct further. Recent chemical and petrochemical prices data by Emkay Global Financial Services indicates that prices of phenol and acetone in November are down 4.9% and 11.4% over October.
Thus, there may not be benefits from rising realisations. Also, the company had achieved its highest-ever plant utilization rate of 120% in 2QFY22, leaving limited growth in this segment for volume accretion, say analysts.
The longer-term prospects nevertheless remain strong and intact. Having fully integrated manufacturing facilities will help it manage and produce chemicals with a competitive advantage. Deepak Phenolics caters to several end-user industries such as agrochemicals, rubber, pharmaceuticals, paper, textile, detergent, colorants, paints, etc. resulting in a natural hedge, say analysts.
Analysts at JM Financial expect βSales, Ebitda and Earnings per share to post 18%, 18%, and 20% CAGR (compound annual growth rate), respectively, over FY21-24E". Despite an aggressive capex of βΉ1,500 crore over FY23-24, they expect its return on capital employed (pre-tax) to remain 32% over FY23E-24E.